These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1668210)

  • 21. Pharmacokinetics of single doses of cefoperazone given by the intravenous and intramuscular routes to unweaned calves.
    Soback S; Ziv G
    Res Vet Sci; 1989 Sep; 47(2):158-63. PubMed ID: 2799072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of some anti-cancer drugs and combined chemotherapy on the pharmacokinetics of antipyrine in the rat.
    Skretkowicz J
    Pol J Pharmacol; 1995; 47(6):519-24. PubMed ID: 8868374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of schistosomiasis infection on the clearance of phenazone in mice.
    Metwally AA; Janku I; Kemper F; Khayyal MT; Ebeid FA; Botros SS
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):206-9. PubMed ID: 2110459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of antipyrine in calves at neonatal period fed with casein supplemented food.
    Janus K
    Arch Vet Pol; 1994; 34(3-4):287-96. PubMed ID: 8891183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diurnal rhythm of phenacetin and antipyrine elimination in rats].
    Starek A; Rachtan R; Piekoszewski W
    Folia Med Cracov; 1990; 31(3):251-8. PubMed ID: 2097289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of spironolactone on antipyrine metabolism in calves.
    Janus K; Suszycka J
    Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in hepatic biotransformation in patients treated with beta-adrenergic drugs and prazosin].
    Adamska-Dyniewska H; Dziekański S
    Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):361-3. PubMed ID: 2626354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in the activity of adenylate- and guanylate cyclase in different rat tissues after chronic administration of ACTH or cortisol].
    Gorshkova TV; Smirnova NB; Afinogenova SA
    Biokhimiia; 1988 Apr; 53(4):626-36. PubMed ID: 2899443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K; Antoszek J
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipyrine disposition in calves. I. Effects of some drugs.
    Depelchin BO; Bloden S; Ansay M
    J Vet Pharmacol Ther; 1987 Mar; 10(1):49-53. PubMed ID: 3586123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of triiodothyronine treatment on pharmacokinetic properties and metabolite formation of antipyrine in dwarf goats.
    Offiah VN; Nijmeijer SM; van Duin CT; Witkamp RF; van Miert AS
    Am J Vet Res; 1992 Aug; 53(8):1354-6. PubMed ID: 1510310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic characteristics of drug substance in liver denervation].
    Ashirmetov AKh; Krakovskiĭ ME
    Farmakol Toksikol; 1989; 52(1):77-80. PubMed ID: 2707429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study to evaluate the effect of a course of ranitidine on antipyrine kinetics.
    Dawson P; Clarke J
    J Clin Pharm Ther; 1987 Feb; 12(1):65-7. PubMed ID: 3449565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistent capacity for adrenocortical response to ACTH administration in pigs.
    Hennessy DP; Stelmasiak T; Johnston NE; Jackson PN; Outch KH
    Am J Vet Res; 1988 Aug; 49(8):1276-83. PubMed ID: 2845841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine repeatability and comparison of the powder and capsule formulations.
    Edeki T; Turner P
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):70-5. PubMed ID: 7757313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.